CureDuchenne Ventures 2020 Pitch Contest Submission Deadline: July 13, 2020!
Rewarding Rare Approaches to Treat Duchenne Muscular Dystrophy
About the Contest:
- Open to colleges, universities, biotech companies and pharma companies in the United States with researchers at all career stages
- Focusing on new Duchenne therapeutics or therapeutic targets, or technology platforms that can help overcome current limitations of Duchenne therapies in development
- Finalists will have opportunity to pitch their idea to a panel of esteemed judges from the drug development and venture capital communities
- Email us at Pitch@CureDuchenne.org if you have any questions
The Winning Details:
- 2 Winners each receiving no-strings attached award of $25,000 by check made out to the winning college, university, or company
- Access to a wide array of experts in Duchenne drug discovery
- Ongoing mentoring from CureDuchenne lead scientists Mike Kelly, PhD & Lianna Orlando, PhD
CureDuchenne Ventures 2020 Pitch Contest
Submission Deadline: July 13, 2020! Two winners each receiving $25,000! For entry details, Official Rules and to meet the judges, please visit: Pitch Contest
Image